NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

Not true.

DC Vax-Direct is designed to treat inoperable solid tumors. The Phase I Trial treated patients with multiple inoperable metastatic tumors who had failed existing treatment regimens. These patients had failed as many as five or six different prior types of treatments, and had generally quite poor life expectancies when they entered the DCVax-Direct Trial. DCVax-Direct was directly injected, with image guidance, into just one of the patients’ tumors and most patients received just three treatments. The Trial included 40 patients, with 39 evaluable, and covered more than a dozen diverse types of solid tumor cancers.

Ref.: https://nwbio.com/nw-bio-presents-updated-data-from-dcvax-direct-phase-i-trial-at-5th-annual-smi-cancer-vaccines-conference-in-london/